| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.09B | 38.29B | 31.68B | 33.20B | 37.50B | 38.00B |
| Gross Profit | 7.65B | 7.01B | 4.59B | 6.60B | 8.74B | 8.70B |
| EBITDA | 4.88B | 4.25B | 3.87B | 4.38B | 6.76B | 6.75B |
| Net Income | 3.27B | 2.70B | 1.10B | 2.41B | 4.99B | 4.87B |
Balance Sheet | ||||||
| Total Assets | 55.80B | 53.81B | 50.30B | 43.00B | 38.77B | 35.44B |
| Cash, Cash Equivalents and Short-Term Investments | 24.05B | 21.36B | 21.51B | 18.12B | 15.04B | 11.63B |
| Total Debt | 6.65B | 6.14B | 5.78B | 6.44B | 6.21B | 6.11B |
| Total Liabilities | 29.20B | 28.51B | 27.42B | 20.82B | 17.88B | 18.61B |
| Stockholders Equity | 26.01B | 24.76B | 22.42B | 21.84B | 20.59B | 16.60B |
Cash Flow | ||||||
| Free Cash Flow | 1.23B | 1.19B | 176.69M | 4.33B | 4.45B | 4.48B |
| Operating Cash Flow | 3.74B | 3.46B | 2.66B | 7.38B | 6.98B | 7.16B |
| Investing Cash Flow | -6.45B | -10.44B | -1.49B | -3.83B | -2.90B | -5.98B |
| Financing Cash Flow | 1.54B | -1.57B | 4.86B | -2.16B | -1.24B | -222.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$3.24B | 11.70 | 8.69% | 3.25% | 19.25% | -10.14% | |
74 Outperform | HK$22.75B | 11.57 | 30.71% | ― | 184.87% | 276.87% | |
62 Neutral | HK$65.43B | 10.48 | 12.87% | 0.82% | 7.53% | 87.77% | |
62 Neutral | HK$61.29B | 19.84 | 13.73% | 1.84% | 17.48% | 10.65% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | HK$9.24B | 6.18 | 9.13% | 3.00% | 17.21% | 166.36% | |
48 Neutral | HK$47.90B | 28.86 | 5.99% | ― | 4.33% | -10.79% |